Featured JAX® Mice for Cancer Research
Browse the most popular and newly emerging models for the study of human cancer including induced, transgenic, and conditional mouse models.
The Jackson Laboratory provides the most widely published and cutting-edge models for oncology research and offers a comprehensive suite of solutions for your oncology research needs.
Over 400 patient-derived xenograft (PDX) tumors are available for engrafting into immunocompromised NSG™ mice for shipment to your facility or use in JAX-directed preclinical efficacy studies.
A robust immuno-oncology platform for efficacy testing of novel immunotherapies targeting T cells and myeloid cells.
I am interested in mammary tumors.
Jennifer Sargent and Mark Warner have won a major publication award, highlighting their work with PDX.
Improving cancer patient outcomes depends on expanding our understanding of basic cancer biology as well as improving...
I am currently engaged in the investigation of the impact of mesenchymal lineage cells and immune-regulatory myeloid cells on adaptive...
Jeff Chuang has summarized the power of 3D cell models and mapped out the key milestones required for implementation of...
In a new paper, Jennifer Trowbridge presents the factors and processes that contribute to Hematopoietic stem cells decline...
Trowbridge has been recognized as an outstanding early-career scientist and will receive a $750,000 award.
The development and providing of the cutting-edge Genome technologies methods for biomedical research.
JAX researchers reveal proteins from two families are consistently activated and likely play a role in promoting chronic inflammation with...